Brief: Hikal Receives US FDA Warning Letter For Jigani Facility
21/08/2025 13:40
Aug 21 (Reuters) - Hikal Ltd HIKA.NS: RECEIVES US FDA WARNING LETTER FOR JIGANI FACILITY Source text: ID:nNSEbtCCzt Further company coverage: HIKA.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Hikal
See all newsBrief: Hikal Begins Commercial Production At New Cgmp Panoli Facility For Personal Care
Brief: Hikal June-Quarter Consol Loss 74 Million Rupees
India's Hikal slips after quarterly profit slump
Brief: Hikal March-Quarter Consol Net Profit 144 Million Rupees
India's Hikal down after revenue reporting discrepancies flagged